RBC Capital Starts Endocyte (ECYT) at Outperform
Tweet
Share
E-mailGet Alerts ECYT Hot Sheet
Price: $23.99 --0%
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 9
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 9
Join SI Premium – FREE
RBC Capital initiates coverage on Endocyte (NASDAQ: ECYT) with an Outperform. PT $14.
For more ratings news on Endocyte click here and for the rating history of Endocyte click here.
Shares of Endocyte closed at $7.94 yesterday.
For more ratings news on Endocyte click here and for the rating history of Endocyte click here.
Shares of Endocyte closed at $7.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Starts SBM Offshore NV (SBMO:NA) (SBFFY) at Outperform
- Wedbush Assumes Rithm Capital Corp. (RITM) at Outperform
- BofA Securities Upgrades Humana (HUM) to Buy, 'The path to $45 EPS power by 2028'
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
